Multivariate analysis confirmed that patients with low miR-200c expression survived longer than the high expression group (hazard ratio, 1.771; 95% CI, 1.081-2.900; p=0.023). There was a trend toward longer disease-free survival in low miR-200c group without statistical significance (p=0.061). Conclusions: The expression of miR-200c may be an important prognosis factor in pancreatic cancer, and it could be a novel therapeutic target of pancreatic cancer. (Korean J Gastroenterol 2015;66:215-220) 
INTRODUCTION
MicroRNA (miRNA) is a small noncoding RNA molecule consisting of 21-25 nucleotides with a complementary base sequence at the 3'-UTR binding site of target genes, suppressing or accelerating protein synthesis of target genes. 1, 2 Since it was first identified from Caenorhabditis elegans in 1993, more than 700 different types of miRNA have been described in human cells. 3, 4 More than 30% of genes are regulated by miRNA, which is involved in differentiation, growth, and proliferation of cells by regulating messenger RNA translation. 5, 6 Aberrantly upregulated or downregulated ex-
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SUBJECTS AND METHODS

Patients
Study subjects were drawn from among patients who were diagnosed with pancreatic cancer and underwent curative surgery in Seoul National University Bundang Hospital 
RNA extraction from pancreatic cancer tissue
RNA from formalin-fixed, paraffin embedded pancreatic cancer tissue was extracted with a nucleic acid extraction kit (Ambion, Austin, TX, USA) and an RNeasyasylic Kit (Qiagen, Tokyo, Japan) according to the manufacturer's instructions. [21] [22] [23] [24] The relative expression of miRNAs of pancreatic cancer tis- 
Statistics
The 
RESULTS
Baseline characteristics of enrolled patients
There were 52 male and 32 female patients ( (Table 3 ). There were no significant differences in miRNA expression in patients in terms of recurrence or recurrence patterns (data not shown). 
